|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8-9
|
|
pubmed:dateCreated |
2010-12-7
|
|
pubmed:abstractText |
Diabetic nephropathy (DN) is the most common cause of end-stage renal disease and improved biomarkers would help identify high-risk individuals. The aim of this study was to discover candidate biomarkers for DN in the plasma peptidome in an in-house cross-sectional cohort (n=122) of type 1 diabetic patients diagnosed with normo-, micro-, and macroalbuminuria.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1862-8354
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
697-705
|
|
pubmed:meshHeading |
pubmed-meshheading:21137087-Apolipoprotein C-I,
pubmed-meshheading:21137087-Automation, Laboratory,
pubmed-meshheading:21137087-Biological Markers,
pubmed-meshheading:21137087-Complement C3b,
pubmed-meshheading:21137087-Diabetic Nephropathies,
pubmed-meshheading:21137087-Humans,
pubmed-meshheading:21137087-Immunomagnetic Separation,
pubmed-meshheading:21137087-Male,
pubmed-meshheading:21137087-Middle Aged,
pubmed-meshheading:21137087-Peptides,
pubmed-meshheading:21137087-Reproducibility of Results,
pubmed-meshheading:21137087-Spectrometry, Mass, Matrix-Assisted Laser...
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Finding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysis.
|
|
pubmed:affiliation |
Hagedorn Research Institute, Novo Nordisk A/S, Gentofte, Denmark.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
